Home › Trial NCT03621904
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
- Trial IDNCT03621904
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorRadboud University Medical Center
- Enrollment150
- Start date2022-10-15
- ConditionsEndometrial Cancer Stage III · Endometrial Cancer Stage IV · Endometrial Cancer Recurrent
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.